Healthcare Industry News: endoscopy
News Release - March 18, 2008
Visionsense Announces Food and Drug Administration (FDA) 510(k) Clearance for VSII - Visionsense Stereoscopic Vision SystemORANGEBURG, N.Y., March 18 (HSMN NewsFeed) -- Visionsense Corp. announces FDA 510(k) Clearance of the new VSII -- Visionsense Stereoscopic Vision System. The system is based on a miniature 3.4 mm distal ("chip-on-a-stick") stereoscopic 3D camera targeting Minimal Invasive laparoscopic and endoscopic Surgery (MIS).
Visionsense's stereoscopic 3D camera enables and enhances MIS surgical procedures that are under served by traditional 2D visualization, in markets such as: Spine, Neurosurgery, Orthopedics, endoscopy, General Surgery, GYN, Robotics, and others.
The company has licensed the technology to various strategic marketing partners, expecting launches later this year.
About Visionsense Corp.
Visionsense exclusively licenses its technology, application or segment specific, to strategic partners, benefiting a unique competitive advantage. The Company develops and manufactures customized Miniature Stereoscopic 3D cameras/sensors that enable surgeons to see "natural" Stereovision, thus enhancing image understanding and hand-eye coordination. These re-useable or disposable cameras are distally assembled on the tip of a flexible / rigid scope or instrument. The technology further assists the surgeon by providing advanced software features, such as image fusion (combining stereovision with MRI, CT or ultrasound for real-time "see-through-tissue") and 3D measurements.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.